Literature DB >> 33080468

D-Carvone inhibit cerebral ischemia/reperfusion induced inflammatory response TLR4/NLRP3 signaling pathway.

Mengyuan Dai1, Lixiu Wu1, Kunqiang Yu1, Ri Xu1, Yanbin Wei2, Arunachalam Chinnathambi3, Tahani Awad Alahmadi4, Minya Zhou5.   

Abstract

To explore the present treatment strategies for ischemic stroke lowered by ischemia-reperfusion (I/R) injury, to hypothesize the effect of d-Carvone on cerebral I/R brain injury induced neuroinflammation through oxidative stress markers mechanism via NRLP3 and TLR4 marker expressions in rat model. The rats were divided into four groups: Sham, I/R vehicle, I/R + D-carvone (10 mg/kg/bw), I/R + D-carvone (20 mg/kg/bw). Supplementation of d-carvone at dose of 10 and 20 m/kg/bw increased the water content, reduced infract volume, attenuated neurological score depicts, furthermore it had antioxidative, anti-inflammatory, and anti-apoptotic effects against cerebral I/R brain injury. In the brain tissues decreased proinflammatory cytokines IL-1β and TNF-α reduced interleukins IL-6, IL-4, IL-10 & VEGF dose dependently, and mRNA expressions of NLRP3, caspase -1, TNF-α, ASC, IL-1β and TLR3 down regulated in cerebral I/R induced rats. Finally d- carvone can successfully improve the cerebral I/R induced rats neuroinflammation, in the hippocampus and cortical areas of the brain finally reduces cerebral I/R induced injury. These results were hypothesized that d-carvone contributed to cerebral stroke associated with the TLR3, giving an excellent therapeutic approach for cerebral I/R brain injury.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia/reperfusion injury; D-Carvone; NLRP3; Neuroinflammation; Oxidative stress; TLR4

Mesh:

Substances:

Year:  2020        PMID: 33080468     DOI: 10.1016/j.biopha.2020.110870

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

Review 1.  NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia-Reperfusion Injury.

Authors:  Lixia Wang; Wei Ren; Qingjuan Wu; Tianzhu Liu; Ying Wei; Jiru Ding; Chen Zhou; Houping Xu; Sijin Yang
Journal:  Front Mol Neurosci       Date:  2022-05-06       Impact factor: 6.261

2.  The Neuroprotective Effect of Shenmai Injection on Oxidative Stress Injury in PC12 Cells Based on Network Pharmacology.

Authors:  Jing Wu; Jiang Wu; Zhonghao Li; Xiaoke Dong; Siyuan Yuan; Jinmin Liu; Le Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-27       Impact factor: 2.650

3.  D-Carvone Attenuates CCl4-Induced Liver Fibrosis in Rats by Inhibiting Oxidative Stress and TGF-ß 1/SMAD3 Signaling Pathway.

Authors:  Hanan A Ogaly; Sharah A A Aldulmani; Fatimah A M Al-Zahrani; Reham M Abd-Elsalam
Journal:  Biology (Basel)       Date:  2022-05-12

4.  Sevoflurane Offers Neuroprotection in a Cerebral Ischemia/Reperfusion Injury Rat Model Through the E2F1/EZH2/TIMP2 Regulatory Axis.

Authors:  Lihua Yang; Hongfei Chen; Lina Guan; Yucan Xu
Journal:  Mol Neurobiol       Date:  2022-01-22       Impact factor: 5.590

5.  Palmatine Protects against Cerebral Ischemia/Reperfusion Injury by Activation of the AMPK/Nrf2 Pathway.

Authors:  Chaoliang Tang; Junmou Hong; Chengyun Hu; Chunxia Huang; Jie Gao; Jun Huang; Di Wang; Qingtian Geng; Yongfei Dong
Journal:  Oxid Med Cell Longev       Date:  2021-03-11       Impact factor: 6.543

6.  DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis.

Authors:  Xiaoyong Zhao; Shan Li; Yunchang Mo; Ruru Li; Shaoyi Huang; Anqi Zhang; Xuqing Ni; Qinxue Dai; Junlu Wang
Journal:  Oxid Med Cell Longev       Date:  2021-10-19       Impact factor: 6.543

7.  Nrf2 protects against cerebral ischemia-reperfusion injury by suppressing programmed necrosis and inflammatory signaling pathways.

Authors:  Weiwei Chen; Xue Teng; Hongmei Ding; Zhiyuan Xie; Ping Cheng; Zhihan Liu; Tao Feng; Xia Zhang; Wenjuan Huang; Deqin Geng
Journal:  Ann Transl Med       Date:  2022-03

8.  Inhibition of PDE10A-Rescued TBI-Induced Neuroinflammation and Apoptosis through the cAMP/PKA/NLRP3 Pathway.

Authors:  Jin Huang; Dang Tang; Yiqiang Cao; Yonggang Wang; Jiang Long; Lin Wei; Hai Song
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-12       Impact factor: 2.650

Review 9.  NLRP3: Role in ischemia/reperfusion injuries.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Yadollah Poornajaf; Bashdar Mahmud Hussen; Yasaman Hajiesmaeili; Atefe Abak; Mohammad Taheri; Ahmad Eghbali
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.